Abate Kristin 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Abate Kristin（CIK 2045943）在 1 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 378 | $450 |
| 2026-09-02 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 19 | $38 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 买入 | 121 | $0 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 53 | $504 |
| 2026-03-03 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 559 | $5,260 |
| 2026-01-29 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 买入 | 92 | $0 |
| 2026-01-29 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 50 | $352 |
| 2026-01-22 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 265 | $1,579 |
| 2025-10-16 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 买入 | 12,799 | $0 |
| 2025-10-03 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 362 | $2,281 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 买入 | 46 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 23 | $148 |
| 2025-09-04 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 12 | $81 |
| 2025-07-23 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | 卖出 | 238 | $952 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02